Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry, check this URL for Tinkerine's Printers: http://www.tinkerine.com/store/3d-printers/
They are selling 3D printers, software and materials, but the only problem is the 3D printers cost too high and only do one color. Other companies, you can buy lower price 3d printers that do 2 color.
You can check the 3d Printers and the price: http://www.tinkerine.com/3d-printers/
Yes, I agree! Long term for more than 10 years.
Yes I agree, I am lucky to get this at .10 and I know AMBS going to be a lot higher by the end of the year.
Wow! Hard to believe AMBS was that low. .007 back in 2 to 3 years. Way to go! You guys made big money from AMBS!
Sound really good about LymPro! All because of LymPro, there will be major milestone and they hope to make LymPro available to clinical trail market in Nov.
Also agreement with ICON will give AMBS access to the global distribution network.
Amarantus on road to commercializing AD test
http://biotuesdays.com/2014/09/23/amarantus-on-road-to-commercializing-ad-test/
No way I would sell, I would be crazy if I did. AMBS believe the milestones will up-list above by the end of 2014. I agree, I do not think it will go lower because most of the short-term sold their shares. Up it will go.
Well Said!
I voted yes too!
Annual Meeting of Stockholders to be held Sept. 22, 2014 at 10:00 a.m. Pacific Time. Will be held at the offices of Wilson Sonsini Goodrich & Rosati at One Market Plaza, Spear Tower, Suite 3300, San Francisco, CA
I guess only the one who can vote can go.
Bascom Palmer Licenses Retinal Disorder Product to Biotech Company
http://med.miami.edu/news/bascom-palmer-licenses-retinal-disorder-product-to-biotech-company
Yes, I agree! This month Solantey did mention that the share price will move above .30 and it will moves to the NASDAQ at $7.00. And kept telling us how good AMBS and will go up to the higher shares. But when he sold most of his shares, that when he tell us it will go down to .07 and lower.
Sorry, it not going to happen. The pps is going up because of the good news on Monday. More than .11 by Tuesday.
Joboggi I am not interested in the chart for AMBS. It what is going to happened when the big Up-List.
From: Gerald E. Commissiong, President & CEO
With that being said, we recognize that it is not optimal to up list from a position of weakness, and therefore we will only consider an up list from a position of strength while the Company is making good progress in the market. We believe the milestones we’ve outlined above – for the end of 2014 alone – will put us in that position. However, if we do not believe we have achieved sufficient shareholder value creation, we will consider delaying the up list until such time as the market recognizes our true value. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/#sthash.Z4x7623N.dpuf
You are hoping to get lower share price. Next week, I really feel it will go a lot higher. We will see on Monday.
We were hoping for that amount, but we did not know when. AMBS did not mention that it will be up at .30
The Up-List I am interested in. You need to be patience.
http://www.marketwatch.com/story/amarantus-bioscience-holdings-inc-fundamental-milestones-ahead-up-listing-from-strength-2014-09-18
You can believe whatever you want. But, you should do your DD about AMBS before your talk.
I checked on google on Amarantus BioScience that want to Up-List on 2013. Sorry, no information.
We recognize that it is not optimal to up list from a position of weakness, and therefore we will only consider an up list from a position of strength while the Company is making good progress in the market. We believe the milestones we’ve outlined above – for the end of 2014 alone – will put us in that position. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/#sthash.BkaTrbiI.ZuFRNpJn.dpuf
Sound good!
I disagree, he the one is giving us good information and also care about the Shareholders.
Misinformation being propagated by short term focused investors that has led to a panic amongst some of our long term shareholders as we head into our inaugural Annual Shareholder’s Meeting (ASM). Primarily, we believe the misinformation being propagated relates to a proposal to increase the Company’s authorized share count. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/#sthash.k0ingu1O.dpuf
www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/
No printers until one to two years and invisible battery. Does not sound good to me.
Phase 2b PD LID clinical trial in the fourth quarter of 2014 or early in 2015.
Would be nice to get more News!
Enjoying the ride! AMBS, I am with you 100%.
Eltoprazine
Amarantus Provides Program Update on Phase 2b Eltoprazine for Parkinson's Disease and Adult ADHD Sept 17, 2014
http://www.marketwatch.com/story/amarantus-provides-program-update-on-phase-2b-eltoprazine-for-parkinsons-disease-and-adult-adhd-2014-09-17
Here to stay for a long time! AMBS I trust!
I have to agree, I do not trust Lincoln Park Capital.
I am so excited about AMBS!
Yes, an excellent presentation! Well Done!
That is so good to know! Can't wait to hear about it.
Amarantus Completes Enrollment of 72 Patient LP-002 Clinical Study for Alzheimer's Blood Diagnostic LymPro Test(R)
http://www.marketwatch.com/story/amarantus-completes-enrollment-of-72-patient-lp-002-clinical-study-for-alzheimers-blood-diagnostic-lympro-testr-2014-09-12
Do your homework, if you not trust 100% then to not buy.
* I would check their Business address on Google.
* Financials
* Check the Chart for so many years back.
* Check information online
* What people say on the message board
* Why pps is not going up and down when people is buying or selling
* There have be a good reason when the pps goes up too fast or down too fast.
* Do your homework, if you not 100% then to not buy.
I trust the CEO. Partnership will help pps go a lot higher.
I agree! CEO (Gerald), Keep up the good work!
I know what you are trying to do, you are trying to get us to sell. This way you can get in at a lower price. You are only thinking about yourself.
Thanks for agreeing!